Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.21
-0.20 (-2.70%)
At close: Feb 20, 2026, 4:00 PM EST
7.27
+0.06 (0.83%)
After-hours: Feb 20, 2026, 7:45 PM EST
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $7.22 million as of February 20, 2026. Its market cap has increased by 20.84% in one year.
Market Cap
7.22M
Enterprise Value
4.44M
1-Year Change
20.84%
Ranking
Category
Stock Price
$7.21
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $7.22M, a decrease of -97.77%. That is a compound annual growth rate of -18.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 7.22M | -11.65% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 7.80M |
| Evogene | 7.67M |
| Alzamend Neuro | 7.49M |
| Mustang Bio | 7.30M |
| Kiora Pharmaceuticals | 7.26M |
| Quoin Pharmaceuticals | 7.22M |
| Aspire Biopharma Holdings | 7.18M |
| PharmaCyte Biotech | 7.12M |